Exposure-Response Analyses of Virologic Response to Glecaprevir and Pibrentasvir in HCV Subjects from Phase 2 and 3 Studies

Lin, CW; Wang, HY; Jiang, Q; Hosmane, B; Shulman, NS; Mensa, FJ; Liu, W

HEPATOLOGY, 2017; 66 ( ): 638A